← Back
Research and new methods

TCR therapy: T cells that “read” inside a cell

In TCR therapy, T cells are given a receptor that recognises protein fragments from inside a cell. In leukaemia this is still mainly research.

Last updated: ~1 min read
A scientist in a white protective suit holding up a test tube beside a microscope
Figure 1.TCR therapy is prepared in specialised laboratories

01Short answer

A CAR sees only markers on the cell surface. The natural T-cell receptor (TCR) recognises small fragments that HLA molecules carry from inside the cell to its surface, so more targets become reachable. The limitation: each TCR works only in patients with a particular HLA type, so tissue type is checked first. Targets such as WT1 are being studied in leukaemia.

02Simple explanation

Inner targets.

HLA type needed.

Individual match.

In trials.

03Scientific explanation

NCI: the T-cell receptor is a protein on the surface of T cells that recognises antigens.

NCI: new treatments are tested step by step, from the laboratory to clinical trials; only those proven safe and beneficial become standard care.

04What happens in the body?

Difference from CAR

A CAR sees the surface; a TCR sees fragments from inside.

Lock and key
Figure 2.Lock and key — TCR therapy: T cells that “read” inside a cell

Who is suitable

Only people with a matching HLA type and target.

A presented fragment
Figure 3.A presented fragment.

How to read the news

Research news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.

Talk to your doctor

Show your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

05From research news to a conversation: four steps

Read, check, ask, decide together.

Read — From a trusted source.1ReadFrom a trusted source.
Check — Phase, participants, result.2CheckPhase, participants, result.
Ask — Show your doctor.3AskShow your doctor.
Decide — Together, without rushing.4DecideTogether, without rushing.
SourceA trusted site.
DoctorA personal explanation.
SafetyNot changing treatment yourself.

06Key points at a glance

TopicIn brief
Difference from CARA CAR sees the surface; a TCR sees fragments from inside.
Who is suitableOnly people with a matching HLA type and target.
How to read the newsResearch news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.
Talk to your doctorShow your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

07Key terms

TCR
T-cell receptor.
HLA
Tissue-matching markers.
Clinical trial
Testing a new treatment with volunteers.
Evidence
A result confirmed by reliable research.

08Key points

  • Learn.
  • Ask your doctor.
  • Write it down.
  • Check the source.
  • Talk to your doctor.

09Frequently asked questions

Is TCR therapy suitable for everyone?

No, it depends on HLA type and the target.

Where can I get it?

Mainly in clinical trials.

Is this advance right for me?

Only your treating doctor can say, based on your diagnosis, stage and condition.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. Is TCR therapy suitable for everyone?

  2. Where can I get it?

  3. Is this advance right for me?

My questions

12Sources

  1. National Cancer Institute. NCI Dictionary of Cancer Terms: T-cell receptor
  2. National Cancer Institute. Immunotherapy to Treat Cancer
  3. National Cancer Institute. CAR T Cells: Engineering Immune Cells to Treat Cancer
  4. National Cancer Institute. What Are Clinical Trials?
  5. National Cancer Institute. Phases of Clinical Trials
  6. National Cancer Institute. Using Trusted Resources
  7. National Cancer Institute. NCI Dictionary of Cancer Terms: liquid biopsy
  8. National Cancer Institute. NCI Dictionary of Cancer Terms: drug resistance
  9. National Cancer Institute. NCI Dictionary of Cancer Terms: menin inhibitor
  10. National Cancer Institute. NCI Dictionary of Cancer Terms: antibody-drug conjugate
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list

Open the interactive site →